Researchers developed PSMA-targeted self-assembling Nano-PROTACs that simultaneously degrade AR, AR-V7, and #HSP90 in castration-resistant #ProstateCancer, achieving up to 78% #TumorInhibition and extended survival. #medsky

#OpenAccess in #STTT: doi.org/10.1038/s413...